Related Articles

• Characterization of circRNAs in established osimertinib‑resistant non‑small cell lung cancer cell lines
• ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
• A retrospective study of the efficacy of combined EGFR‑TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR‑TKI monotherapy for PD‑L1‑positive EGFR‑mutant non‑small cell lung cancer: North Japan Lung Cancer Study Group 2202
• Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non‑small cell lung cancer
• Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)